Switch from Calcineurin Inhibitors to Belatacept in Kidney Transplant patients with chronic-active Antibody Mediated Rejection results in a lower decline in Kidney Transplant function at three years
Switch des anti-calcineurines au Belatacept chez les patients transplantés rénaux présentant un rejet humoral chronique-actif